series-c-plus
Stage
5
Investors
About
Magenta Medical develops novel percutaneous left ventricular assist devices (LVAD) for temporary circulatory support. These devices are designed for use during high-risk percutaneous coronary interventions and for patients experiencing cardiogenic shock.
Explore Magenta Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.